Co-occurring tobacco use and posttraumatic stress disorder: Smoking cessation treatment implications

2015 ◽  
Vol 24 (8) ◽  
pp. 695-704 ◽  
Author(s):  
Megan M. Kelly ◽  
Kevin P. Jensen ◽  
Mehmet Sofuoglu
Keyword(s):  
Posttraumatic Stress Disorder ◽  
Smoking Cessation ◽  
Posttraumatic Stress ◽  
Tobacco Use ◽  
Stress Disorder ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment

Survey of providers' attitudes toward integrating smoking cessation treatment into posttraumatic stress disorder care.

2013 ◽  
Vol 27 (1) ◽  
pp. 249-255 ◽  
Author(s):  
Carol A. Malte ◽  
Miles McFall ◽  
Bruce Chow ◽  
Jean C. Beckham ◽  
Timothy P. Carmody ◽  
...  
Keyword(s):  
Posttraumatic Stress Disorder ◽  
Smoking Cessation ◽  
Posttraumatic Stress ◽  
Stress Disorder ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment

scholarly journals A Qualitative Examination of Stay Quit Coach, A Mobile Application for Veteran Smokers With Posttraumatic Stress Disorder

2019 ◽  
Vol 22 (4) ◽  
pp. 560-569
Author(s):  
Ellen Herbst ◽  
Shannon E McCaslin ◽  
Shahrzad Hassanbeigi Daryani ◽  
Kelsey T Laird ◽  
Lindsey B Hopkins ◽  
...  
Keyword(s):  
Posttraumatic Stress Disorder ◽  
Smoking Cessation ◽  
Mobile Technology ◽  
Stress Disorder ◽  
Military Veterans ◽  
Evidence Based ◽  
Smoking Cessation Treatment ◽  
Us Military ◽  
Cessation Treatment ◽  
Promote Smoking Cessation

Abstract Introduction Smoking is a lethal public health problem that is common in US military veterans, particularly those with posttraumatic stress disorder (PTSD). Mobile applications (apps) to promote smoking cessation are a scalable and low-cost approach that may facilitate treatment engagement. Methods This qualitative study examined the acceptability, user experience, and perceptions of a smoking cessation app, Stay Quit Coach (SQC), when incorporated into evidence-based smoking cessation treatment. US military veterans with PTSD who smoked at least five cigarettes per day for 15 of the past 30 days and stated an interested in cessation were eligible to participate. Participants’ baseline comfort levels with mobile technology was measured using the Perceptions of Mobile Phone Interventions Questionnaire–Patient version (PMPIQ-P). At treatment end, semi-structured qualitative interviews were conducted. Results Twenty participants were enrolled and 17 (85.0%) participated in the qualitative interview at treatment end. PMPIQ-P scores at baseline ranged from 4.97 to 5.25 (SDs = 0.73–1.04), reflecting moderately high comfort with mobile technology among participants. Qualitative analyses indicated that most participants: (1) endorsed mobile technology as an appealing format for smoking cessation treatment, due to convenience and instantaneous access; and (2) expressed highest perceived helpfulness for interactive app features. Recommendations to improve SQC clustered into four thematic areas: (1) increasing personalization, (2) including more self-tracking features, (3) increasing visual cues, and (4) sharing progress with peers. Conclusions SQC was perceived as an acceptable and useful tool to support smoking cessation in a sample of veteran smokers with PTSD. Qualitative data provided valuable insights that can inform the continued development of SQC and other apps for smoking cessation. Implications Given the high lethality associated with cigarette smoking, it is crucial to identify scalable, low-risk strategies to promote smoking cessation, particularly in high-risk populations. Mobile technology is a promising approach that can be used to augment evidence-based smoking cessation treatment. Results of this qualitative study support the use of the SQC mobile app when incorporated into evidence-based smoking cessation treatment for veterans with PTSD and provide future directions for refinement of the SQC app. These findings also highlight the importance of using a patient-centered approach in designing apps intended for a clinical population.

scholarly journals Pilot Cases of Combined Cognitive Processing Therapy and Smoking Cessation for Smokers With Posttraumatic Stress Disorder

2016 ◽  
Vol 47 (1) ◽  
pp. 54-65 ◽  
Author(s):  
Eric A. Dedert ◽  
Patricia A. Resick ◽  
Miles E. McFall ◽  
Paul A. Dennis ◽  
Maren Olsen ◽  
...  
Keyword(s):  
Posttraumatic Stress Disorder ◽  
Smoking Cessation ◽  
Posttraumatic Stress ◽  
Cognitive Processing ◽  
Stress Disorder ◽  
Cognitive Processing Therapy

scholarly journals Public health clinical demonstration project for smoking cessation in veterans with posttraumatic stress disorder

2010 ◽  
Vol 35 (1) ◽  
pp. 19-22 ◽  
Author(s):  
Eric A. Dedert ◽  
Sarah M. Wilson ◽  
Patrick S. Calhoun ◽  
Scott D. Moore ◽  
Kim W. Hamlett-Berry ◽  
...  
Keyword(s):  
Public Health ◽  
Posttraumatic Stress Disorder ◽  
Smoking Cessation ◽  
Posttraumatic Stress ◽  
Stress Disorder ◽  
Demonstration Project

scholarly journals Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Use Disorder and Serious Mental Illness

2019 ◽  
Vol 22 (9) ◽  
pp. 1533-1542 ◽  
Author(s):  
Roger Vilardaga ◽  
Javier Rizo ◽  
Paige E Palenski ◽  
Paolo Mannelli ◽  
Jason A Oliver ◽  
...  
Keyword(s):  
Mental Illness ◽  
Randomized Controlled Trial ◽  
Smoking Cessation ◽  
Tobacco Use ◽  
Controlled Trial ◽  
Smoking Cessation Treatment ◽  
Tobacco Use Disorder ◽  
Randomized Controlled ◽  
Cessation Treatment ◽  
Pilot Randomized Controlled Trial

Abstract Introduction High rates of tobacco use among people with serious mental illness (SMI), along with their unique needs, suggest the importance of developing tailored smoking cessation interventions for this group. Previous early-phase work empirically validated the design and content of Learn to Quit, a theory-based app designed for this population. Methods In a pilot randomized controlled trial, we compared the feasibility, acceptability, and preliminary efficacy of Learn to Quit versus QuitGuide, an app designed for the general population. All participants received nicotine replacement therapy and technical assistance. Daily smokers with SMI (N = 62) participated in the trial with outcomes assessed at weeks 4, 8, 12, and 16. Results Compared to QuitGuide, Learn to Quit participants had similar number of days of app use (34 vs. 32, p = .754), but larger number of app interactions (335 vs. 205; p = .001), longer durations of app use (4.24 hrs. vs. 2.14 hrs; p = .044), and higher usability scores (85 vs. 79, p = .046). At week 16, Learn to Quit led to greater reductions in cigarettes per day (12.3 vs. 5.9 for QuitGuide; p = 0.10). Thirty-day point prevalence abstinence was verified in 12% of Learn to Quit participants versus 3% of QuitGuide participants (odds ratio = 3.86, confidence interval = 0.41 to 36, p = .239). Changes in psychiatric symptoms and adverse events were not clinically significant between conditions. Conclusions This pilot trial provides strong evidence of Learn to Quit’s usability, feasibility, and safety. Preliminary evidence suggests the app may be efficacious. A randomized controlled efficacy trial is needed to test the app in a larger sample of smokers with SMI. Implications This study suggests that the Learn to Quit app is a feasible approach to deliver smoking cessation treatment in patients with co-occurring tobacco use disorder and SMI. This means that, if found efficacious, this technology could be used to deploy smoking cessation treatment to larger segments of this population, hence improving public health. Therefore, a randomized controlled trial should be conducted to examine the efficacy of this digital intervention.

Pharmacy considerations in tobacco cessation for patients suffering from posttraumatic stress disorder

2013 ◽  
Vol 2 (7) ◽  
pp. 195-201
Author(s):  
Allen Ayala ◽  
Melanie Geer
Keyword(s):  
Posttraumatic Stress Disorder ◽  
Posttraumatic Stress ◽  
Tobacco Use ◽  
Post Traumatic Stress Disorder ◽  
Traumatic Stress ◽  
Tobacco Cessation ◽  
Stress Disorder ◽  
Post Traumatic Stress ◽  
Post Traumatic ◽  
Different Populations

Multiple studies have associated post traumatic stress disorder (PTSD) with variable and high rates of smoking documented in different populations. This article will cover the neurobiology behind tobacco use, and its implications in those with PTSD. Discussion on cessation programs (e.g., effectiveness, drug interactions), and controversy over the use of varenicline will also be discussed.

Integrating Tobacco Cessation Treatment into Mental Health Care for Patients with Posttraumatic Stress Disorder

2006 ◽  
Vol 15 (5) ◽  
pp. 336-344 ◽  
Author(s):  
Miles McFall ◽  
David C. Atkins ◽  
Dan Yoshimoto ◽  
Charles E. Thompson ◽  
Evan Kanter ◽  
...  
Keyword(s):  
Mental Health ◽  
Health Care ◽  
Posttraumatic Stress Disorder ◽  
Mental Health Care ◽  
Posttraumatic Stress ◽  
Tobacco Cessation ◽  
Stress Disorder ◽  
Cessation Treatment
Sign in / Sign up

Export Citation Format

Share Document